Data as of Q4 2025 (Dec 31, 2025)

Hillman Capital Management, Inc.

โ€ขCIK: 1314620โ€ขFiling: Q4 2025

**Hillman Capital Management, Inc.** manages $159M across a portfolio of 56 distinct positions. The firm exhibits notable concentration in key names, with top holdings including WBD at $6.2M and ASML at $5.9M. Further significant allocations are observed in EL, CVS, and GSK, each representing approximately $5.7M. This positioning suggests a tactical, multi-sector approach targeting established market leaders.

Total AUM
$158.9M
QoQ Performance
-7.5%
Positions
52
Top 10 Concentration
35.1%
Latest Filing
Q4 2025

Top Holdings Allocation

WBD3.9%
ASML3.7%
EL3.6%
CVS3.6%
GSK3.5%
BA3.5%
BIIB3.4%
DD3.4%

๐Ÿ“ˆ Biggest Buys

SPY
SPDR S&P 500 ETF TR
NEW
2.9% of portfolio
DD
DUPONT DE NEMOURS INC
+87.2%
3.4% of portfolio
AKAM
AKAMAI TECHNOLOGIES INC
+655.9%
1.8% of portfolio
FISV
FISERV INC
+67.6%
1.6% of portfolio
KMX
CARMAX INC
+21.4%
2.7% of portfolio

๐Ÿ“‰ Biggest Sells

WBD
WARNER BROS DISCOVERY INC
-35.1%
3.9% of portfolio
NUE
NUCOR CORP
-88.0%
0.3% of portfolio
EL
LAUDER ESTEE COS INC
-22.5%
3.6% of portfolio
BIIB
BIOGEN INC
-20.4%
3.4% of portfolio
ASML
ASML HOLDING N V
-18.6%
3.7% of portfolio

Sector Breakdown

Other62.7%
Healthcare10.2%
Technology6.8%
Industrial5.5%
Communication3.5%
ETF3.3%
Consumer2.7%
Consumer Staples2.7%

Changes from Q3 2025

NEW3 new positions
โ†‘8 increased
โ†“44 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023